Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • Newsletter
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 1646
  • 1647
  • 1648
  • …
  • ›
  • »

2026-08-25

Why IMAX Stock Climbed to a New All-Time High Today

2026-08-25

XPENG-W Gaps Down 8% at Open; 2Q Adj. Net Loss Widens to RMB1.237B, Misses Forecasts

2026-08-25

CIMC ENRIC Subsidiary Wins Preliminary Bids for Two Major Beer Brewing Projects and Intelligent Pickled Vegetable Production Project

2026-08-25

Warning: KAISA GROUP Expects Interim Loss to Narrow to Up to RMB9.5B

2026-08-25

Results: VCREDIT Interim Net Profit RMB13.376M Down 93.8% YoY

2026-08-25

Results: GOLDPAC GROUP Swings to Interim Loss of RMB14.593M

2026-08-25

Fortescue stands down executive at the centre of harassment probe

2026-08-25

Why is everyone talking about Coles, Ramelius Resources and Woodside shares on Tuesday?

2026-08-25

PDD (PDD) Q2 2026 Earnings Call Transcript

2026-08-25

Coles profit climbs 13% as supermarket sales and online groceries drive growth

2026-08-25

Results: TUYA-W Interim Net Profit Up 45.8% to USD34.41M

2026-08-25

LEADS BIOLABS-B Velaixin Phase II Study for Esophageal Squamous Cell Carcinoma Enters Expansion Stage

  • «
  • ‹
  • …
  • 1646
  • 1647
  • 1648
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies